Cure pharmaceutical announces promotions and additions to board of directors

Oxnard, calif.--(business wire)---- $curr #cbd--cure pharmaceutical holdings (“cure” or the “company”) (otc: curr), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today updates and additions to its board of directors. after a dedicated run as chairman of the board, william yuan is stepping down and will continue to serve the company as an advisor and chairman emeritus. rubÉn josÉ king-shaw jr, a highly qualified and respected member of
CURR Ratings Summary
CURR Quant Ranking